[1] Tong J G.Poorly controlled postoperative pain: prevalence, consequences, and prevention[J].J Pain Res, 2017, 10:2287-2298.
[2] 李仁虎, 李元海, 徐 露,等.1200例全麻患者术后躁动原因分析及防治[J].安徽医药, 2011, 15(2):186-188.
[3] Benyamin R,Trescot A M,Datta S,et al. Opioid complica-tions and side effects[J]. Pain Physician,2008,11 (2 Sup-pl) : S105 - S120.
[4] Manchikanti L,Vallejo R,Manchikanti K N,et al. Effective-ness of long-term opioid therapy for chronic non-cancer pain[J]. Pain Physician,2011,14(2):E133-E156.
[5] Chapman C R,Lipschitz D L,Angst M S,et al. Opioid pharma-cotherapy for chronic non-cancer pain in the United States:a research guideline for developing an evidence-base[J].J Pain,2010,11(9):807-829.
[6] Jennings E M, Okine B N, Roche M, et al.Stress-induced hyperalgesia.[J].Prog Neurobiol, 2014, 121:1-18.
[7] Lä Y F, Yang Y, Li C L, et al.The Locus Coeruleus-Norepinephrine System Mediates Empathy for Pain through Selective Up-Regulation of P2X3 Receptor in Dorsal Root Ganglia in Rats[J].Front Neural Circuits, 2017, 11:66.
[8] Correa-Sales C, Rabin B C, Maze M.A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.[J].Anesthesiology, 1992, 76(6):948-952.
[9] Tamagaki S, Suzuki T, Hagihira S, et al.Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn.[J].J Pharm Pharmacol, 2010, 62(12):1760.
[10] Pirbudak L, Maralcan G.Pain management with intrathecal clonidine in a colon cancer patient with opioid hyperalgesia: case presentation.[J].Agri.2014, 26(2):93-96.
[11] 邢艳红.可乐定与右美托咪定对神经病理性痛大鼠背根神经节生长相关蛋白-43mRNA表达的影响[D].兰州大学,2012.
[12] Jo J Y, Choi S S, Yi J M, et al.Differential Postoperative Effects of Volatile Anesthesia and Intraoperative Remifentanil Infusion in 7511 Thyroidectomy Patients: A Propensity Score Matching Analysis[J].Medicine, 2016, 95(7):e2764.
[13] 陶 佳,顾小萍,彭良玉,等.右美托咪定预先给药对术后疼痛及瑞芬太尼痛觉过敏的影响[J].临床麻醉学杂志,2011,27(10):947-949.
[14] 孙 静,吴 斌,胡衍辉,等.右美托咪定对瑞芬太尼诱发痛觉过敏的影响[J].临床麻醉学杂志,2013,29(4):356-358.
[15] 张 卫,周立君,阚全程,等.不同剂量右美托咪定与小剂量氯胺酮预防瑞芬太尼复合麻醉后痛觉过敏的效果比较[J].临床麻醉学杂志,2013,29(5):435-438.
[16] Lee C, Kim Y D, Kim J N.Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia[J].Korean J Anesthesiol, 2013, 64(4):301-307.
[17] Zheng Y, Cui S, Liu Y, et al.Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit[J].Brain Res Bull, 2012, 87(4-5):427.
[18] 常 路,叶 芳,舒海华,等.芬太尼诱导的大鼠急性痛觉过敏和脊髓炎性反应有关[J].中山大学学报(医学科学版),2017,38(1):15-20.
[19] 高 强,原大江.痛觉过敏机制的研究新进展[J].中华临床医师杂志(电子版),2016,10(8):1172-1177.
[20] 刘永峰,杨承祥.坐骨神经周围注射可乐定对CCI大鼠促炎性细胞因子表达的影响[J].包头医学院学报,2009,25(5):19-22.
[21] Yamakita S, Matsuda M, Yamaguchi Y, et al.Dexmedetomidine prolongs levobupivacaine analgesia via inhibition of inflammation and p38 MAPK phosphorylation in rat dorsal root ganglion [J].Neuroscience, 2017, 361:58.
[22] Zheng Y, Cui S, Liu Y, et al.Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit.[J].Brain Res Bull, 2012, 87(4-5):427.
[23] Lu Y,Lin B,Zhong J.The therapeutic effect of dexmedetomidine on rat diabetic neuropathy pain and the mechanism.[J].Biol Pharm Bull, 2017,40(9):1432-1438.
[24] Faber ESL,Chambers J P,Evans R H.Depression of NMDA receptor-mediated synaptic trasmission by four a2 adrenoceptor agonists on the in vitro rat spinal cord preparation [J],Br J Phamaco,1998,124(3):507-512.
[25] Yuan Y, Zhe S, Yi C,et al.Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro[J].Plos One, 2017, 12(2):e0171348.